Apic Bio Competitors and Similar CompaniesClear all

FinVector's competitors and similar companies include Stoke Therapeutics.
FinVector
FinVector
FinVector is a company engaged in the research and development of gene and cell therapies.
Stoke Therapeutics
Stoke Therapeutics
Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
Founding Date
Founding Date
2013
Founding Date
2014
Type
Type
Private
Type
Public
Tags
Locations
Locations
Kuopio, FI HQ
Locations
Bedford, US HQ
Cambridge, US
Employees
Employees
338
Employees
1106% decrease
For sources of this data, please see the company profile

View Company Profiles

Stoke Therapeutics
HQ
Bedford, US
Employees
110↓ 6% decrease

Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.

View company